Comparative risk of infections among JAK inhibitors used in rheumatoid arthritis: A network meta-analysis of clinical trials

被引：0
|
作者：
Alves, Carlos [1 ,2 ]
Mendes, Diogo [2 ]
Penedones, Ana [1 ,2 ]
Marques, Francisco Batel [1 ,2 ]
机构：
[1] Univ Coimbra, Sch Pharm, Coimbra, Portugal
[2] AIBILI Assoc Innovat & Biomed Res Light & Image, Coimbra, Portugal
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2020年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
4461
引用
收藏
页码：130 / 130
页数：1
相关论文
共 50 条
  • [41] POOLED ANALYSIS OF THE RISK OF SERIOUS INFECTIONS AND OPPORTUNISTIC INFECTIONS IN CLINICAL TRIALS OF CERTOLIZUMAB PEGOL FOR RHEUMATOID ARTHRITIS
    Mariette, X.
    Bertin, P.
    Arendt, C.
    Terpstra, I.
    VanLunen, B.
    de Longueville, M.
    RHEUMATOLOGY, 2012, 51 : 132 - 132
  • [42] A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview
    Singh, Jasvinder A.
    Christensen, Robin
    Wells, George A.
    Suarez-Almazor, Maria E.
    Buchbinder, Rachelle
    Lopez-Olivo, Maria Angeles
    Ghogomu, Elizabeth Tanjong
    Tugwell, Peter
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2009, 181 (11) : 787 - 796
  • [43] Risk of tuberculosis in patients with rheumatoid arthritis treated with biological and targeted drugs: meta-analysis of randomized clinical trials
    Ji Xiaojian
    Hu Lidong
    Wang Yiwen
    Man Siliang
    Liu Xingkang
    Song Chuan
    Zhang Jiaxin
    Zhu Jian
    Zhang Jianglin
    Huang Feng
    中华医学杂志英文版, 2022, 135 (04) : 409 - 415
  • [44] The Risk of Hyperglycaemia with the Use of Rituximab in Rheumatoid Arthritis. Results from a Meta-analysis of Randomised Clinical Trials
    Velez-Nandayapa, L.
    DeVore, L.
    Parikh, C.
    DRUG SAFETY, 2016, 39 (10) : 997 - 997
  • [45] Risk of tuberculosis in patients with rheumatoid arthritis treated with biological and targeted drugs: meta-analysis of randomized clinical trials
    Ji, Xiaojian
    Hu, Lidong
    Wang, Yiwen
    Man, Siliang
    Liu, Xingkang
    Song, Chuan
    Zhang, Jiaxin
    Zhu, Jian
    Zhang, Jianglin
    Huang, Feng
    CHINESE MEDICAL JOURNAL, 2022, 135 (04) : 409 - 415
  • [46] Comparative Effectiveness of Tofacitinib Versus Baricitinib in Rheumatoid Arthritis Using a Systematic Review and Network Meta-Analysis of Randomized Trials
    Zamora, Natalia
    Lopez-Olivo, Maria A.
    Tayar, Jean
    Christensen, Robin
    Suarez-Almazor, Maria
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [47] Risk of infections and cardiovascular and venous thromboembolic events associated with JAK inhibitors in rheumatoid arthritis: protocols of two systematic reviews and network meta-analyses
    Alves, Carlos
    Penedones, Ana
    Mendes, Diogo
    Batel-Marques, Francisco
    BMJ OPEN, 2020, 10 (12):
  • [48] Effect of JAK inhibitors on high- and low-density lipoprotein in patients with rheumatoid arthritis: a systematic review and network meta-analysis
    Na Li
    Zhong-Ping Gou
    Shuang-Qing Du
    Xiao-Hong Zhu
    Hui Lin
    Xiu-Fang Liang
    Yong-Sheng Wang
    Ping Feng
    Clinical Rheumatology, 2022, 41 : 677 - 688
  • [49] Adalimumab in rheumatoid arthritis treatment: a systematic review and meta-analysis of randomized clinical trials
    de Avila Machado, Marina Amaral
    Maciel, Alessandra Almeida
    Pires de Lemos, Livia Lovato
    Costa, Juliana Oliveira
    Kakehasi, Adriana Maria
    Gurgel Andrade, Eli Iola
    Cherchiglia, Mariangela Leal
    Acurcio, Francisco de Assis
    REVISTA BRASILEIRA DE REUMATOLOGIA, 2013, 53 (05) : 419 - 430
  • [50] Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism with JAK Inhibitors versus TNF Inhibitors in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis
    Partalidou, Styliani
    Patoulias, Dimitrios
    Deuteraiou, Kleopatra
    Avgerou, Paraskevi
    Kitas, George
    Tzitiridou-Chatzopoulo, Maria
    Dimitroulas, Theodoros
    MEDITERRANEAN JOURNAL OF RHEUMATOLOGY, 2024, 35 (01):
12345